Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

IGBA Calls on all Stakeholders to Join the Biosimilars… 1 November 2021 <strong><a class="button small empty" href="https://www.medicinesforeurope.com/wp-content/uploads/2021/11/IGBA-Calls-on-all-Stakeholders-to-Join-the-Biosimilars-Movement-on-Advancing-Access.pdf">Read more</a></strong>
Interview: Medicines for Europe Reports on EU Biosimilar… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…
Biosimilars ‒ Policy failings that deny savings to countries… 21 November 2019 Read more
Generic & biosimilar medicines pivotal for safe, effective… 28 November 2019 The European Commission has identified the use of generic and…